201 related articles for article (PubMed ID: 33909551)
1. Whole genome sequencing of a clinical drug resistant
Khalaf RA; Fattouh N; Medvecky M; Hrabak J
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33909551
[No Abstract] [Full Text] [Related]
2. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
[TBL] [Abstract][Full Text] [Related]
3. Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
Vale-Silva LA; Coste AT; Ischer F; Parker JE; Kelly SL; Pinto E; Sanglard D
Antimicrob Agents Chemother; 2012 Apr; 56(4):1960-8. PubMed ID: 22252807
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
Toutounji M; Tokajian S; Khalaf RA
Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence.
Lohberger A; Coste AT; Sanglard D
Eukaryot Cell; 2014 Jan; 13(1):127-42. PubMed ID: 24243794
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
Barker KS; Crisp S; Wiederhold N; Lewis RE; Bareither B; Eckstein J; Barbuch R; Bard M; Rogers PD
J Antimicrob Chemother; 2004 Aug; 54(2):376-85. PubMed ID: 15201233
[TBL] [Abstract][Full Text] [Related]
7. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
Dunkel N; Liu TT; Barker KS; Homayouni R; Morschhäuser J; Rogers PD
Eukaryot Cell; 2008 Jul; 7(7):1180-90. PubMed ID: 18487346
[TBL] [Abstract][Full Text] [Related]
8. Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs.
Mount HO; Revie NM; Todd RT; Anstett K; Collins C; Costanzo M; Boone C; Robbins N; Selmecki A; Cowen LE
PLoS Genet; 2018 Apr; 14(4):e1007319. PubMed ID: 29702647
[TBL] [Abstract][Full Text] [Related]
9. Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance.
Branco J; Ola M; Silva RM; Fonseca E; Gomes NC; Martins-Cruz C; Silva AP; Silva-Dias A; Pina-Vaz C; Erraught C; Brennan L; Rodrigues AG; Butler G; Miranda IM
Clin Microbiol Infect; 2017 Aug; 23(8):575.e1-575.e8. PubMed ID: 28196695
[TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
MacCallum DM; Coste A; Ischer F; Jacobsen MD; Odds FC; Sanglard D
Antimicrob Agents Chemother; 2010 Apr; 54(4):1476-83. PubMed ID: 20086148
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Chemical Screen Identifies a 2,5-Disubstituted Pyridine as an Inhibitor of Candida albicans Erg11.
Du Bois AC; Xue A; Pham C; Revie NM; Meyer KJ; Yashiroda Y; Boone C; Nodwell JR; Stogios P; Savchenko A; Robbins N; Iyer KR; Cowen LE
mSphere; 2022 Jun; 7(3):e0007522. PubMed ID: 35531664
[TBL] [Abstract][Full Text] [Related]
12. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
Rocha MFG; Bandeira SP; de Alencar LP; Melo LM; Sales JA; Paiva MAN; Teixeira CEC; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Brilhante RSN
Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
[TBL] [Abstract][Full Text] [Related]
13. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a
Zhang C; Wang W; Kong Q; Liu F; Chen J; Sang H
Mycologia; 2019; 111(6):942-952. PubMed ID: 31622176
[No Abstract] [Full Text] [Related]
16. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
[TBL] [Abstract][Full Text] [Related]
17. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
Zhang MR; Zhao F; Wang S; Lv S; Mou Y; Yao CL; Zhou Y; Li FQ
BMC Infect Dis; 2020 Feb; 20(1):126. PubMed ID: 32046674
[TBL] [Abstract][Full Text] [Related]
19. The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn.
Lv QZ; Yan L; Jiang YY
Virulence; 2016 Aug; 7(6):649-59. PubMed ID: 27221657
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
